Can the UK deliver on its ambitions for the Life Sciences sector?
Yesterday I attended the excellent PING conference where speakers presented the UK vision for the Life Sciences. This includes seven missions for Healthcare:
These are all important ambitions and the pharmaceutical industry is keen to play its part in achieving them.
However, I have a serious concern that whilst espousing these laudable ambitions the UK is at the same time seriously undermining the MHRA, who will need to play a central role in realising these aims. The MHRA is currently undergoing a major reorganisation, which is cutting 20% of their staff and is resulting in many of their most experienced people departing the Agency. So will the UK actually be able to achieve their Healthcare Mission with a diminished MHRA?